LncRNAs that are involved in both embryogenesis and glioma biology (e.g: CRNDE, HOTAIRM1, ADAMTS9‐AS2), with expression levels controlled by epigenetic mechanisms, could represent a future option for further studies on epigenetic therapy for glioma patients. This evidence concerns the gene ADAMTS9 and central nervous system cancer.